| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Gifted 2,290,000 shares
@ $0 |
|
| 08/21/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,245 shares
@ $8.46, valued at
$19k
Paid exercise price by delivering 3,965 shares
@ $8.46, valued at
$33.5k
Exercised 6,758 restricted stock units
@ $0
Exercised 11,781 restricted stock units
@ $0 |
|
| 08/08/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $9.04, valued at
$180.8k
|
|
| 07/07/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $8.48, valued at
$169.6k
|
|
| 06/07/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $8.23, valued at
$164.6k
|
|
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,633 shares
@ $6.69, valued at
$17.6k
Paid exercise price by delivering 2,951 shares
@ $6.69, valued at
$19.7k
Exercised 6,758 restricted stock units
@ $0
Exercised 7,854 restricted stock units
@ $0 |
|
| 05/10/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $11.55, valued at
$231k
|
|
| 05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/07/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $10.13, valued at
$202.6k
Granted 284,900 options to buy
@ $10.61, valued at
$3M
Granted 188,501 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,633 shares
@ $10.97, valued at
$28.9k
Exercised 6,758 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $13.19, valued at
$263.8k
|
|
| 01/10/2023 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $10.66, valued at
$213.2k
|
|
| 12/09/2022 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Gifted 10,000 shares
@ $0
Sold 20,000 shares
@ $11.86, valued at
$237.2k
|
|
| 11/22/2022 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,264 shares
@ $14.75, valued at
$33.4k
Exercised 6,758 restricted stock units
@ $0 |
|
| 11/08/2022 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $14.76, valued at
$295.2k
|
|
| 10/11/2022 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $14.79, valued at
$295.8k
|
|
| 09/09/2022 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $12.89, valued at
$257.8k
|
|
| 08/19/2022 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,479 shares
@ $14.06, valued at
$34.9k
Exercised 6,758 restricted stock units
@ $0 |
|
| 08/10/2022 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $15.09, valued at
$301.8k
|
|
| 07/08/2022 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $11.19, valued at
$223.8k
|
|
| 06/09/2022 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $10.75, valued at
$215k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| Jiang Wenbin (President and CEO) has filed a Form 4 on Cytek Biosciences, Inc.|
Txns:
| Sold 20,000 shares
@ $10.54, valued at
$210.8k
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
SC 13G
| Jiang Wenbin reports a 6% stake in Cytek Biosciences, Inc. |
| 02/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2021 |
3
| Jiang Wenbin (President and CEO) has filed a Form 3 on Cytek BioSciences, Inc. |